--- title: "Shanghai Composite Index Volatile Up, Innovative Drugs and Auto Stocks Rally Mid-day, Commercial Aerospace Active, Hang Seng Tech Index Surges and Falls Back, Tech Stocks Diverge" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/281111117.md" description: "The automotive vehicle sector showed strength, with the bus segment leading the gains. Yutong Bus and SG Automotive Group both hit the daily limit, while Zhongtong Bus Holding Co.,LTD, KLM, JMC, and Ankai saw significant increases. The commercial aerospace concept continued its strong performance, with SHENJIAN GUFEN up for 4 consecutive trading days, followed by SHUNHO STOCK, Shaoyang Hydraulic, Zhongheng Design, Jullyar, and Chaojie Precision. Innovative drug stocks were repeatedly active, with TJPC up for 3 consecutive trading days, followed by Asymchem, Biosan, Pharmaron, HITECK, and Novus Therapeutics" datetime: "2026-03-31T08:37:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281111117.md) - [en](https://longbridge.com/en/news/281111117.md) - [zh-HK](https://longbridge.com/zh-HK/news/281111117.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281111117.md) | [English](https://longbridge.com/en/news/281111117.md) # Shanghai Composite Index Volatile Up, Innovative Drugs and Auto Stocks Rally Mid-day, Commercial Aerospace Active, Hang Seng Tech Index Surges and Falls Back, Tech Stocks Diverge On March 31st, A-shares saw a volatile rise, with the Shanghai Composite Index further increasing in morning trading. The ChiNext Index opened lower before recovering, and sectors such as automotive vehicles and innovative drugs rallied, while concepts like commercial aerospace and satellite navigation were active. Hong Kong stocks surged and then retreated in morning trading, with the Hang Seng Index and Hang Seng Tech Index narrowing their gains. The Hang Seng Tech Index had previously risen by 1%, and tech stocks diverged. In terms of the bond market, treasury futures mostly saw a volatile rise. In terms of commodities, domestic commodity futures experienced a broad decline, with only metal futures such as Shanghai silver and Shanghai gold rising against the trend. Core Market Performance: > **A-shares**: As of press time, the Shanghai Composite Index rose by 0.45%, the Shenzhen Component Index rose by 0.11%, and the ChiNext Index fell by 0.41%. > > > > **Hong Kong Stocks**: As of press time, the Hang Seng Index rose by 0.15%, and the Hang Seng Tech Index rose by 0.24%. > > > > **Bond Market**: Treasury futures saw a volatile rise. As of press time, the 30-year main contract rose by 0.02%, the 10-year main contract rose by 0.04%, the 5-year main contract rose by 0.02%, and the 2-year main contract fell by 0.01%. > > > > **Commodities**: Most domestic commodity futures declined. As of press time, Shanghai silver and Shanghai gold rose against the trend. Metal futures such as platinum, palladium, Shanghai tin, Shanghai aluminum, and Shanghai copper rose. Eggs, hot-rolled coil, rebar, Shanghai nickel, iron ore, polysilicon, rubber, manganese silicon, soybean meal, pulp, and stainless steel declined. Industrial silicon, asphalt, and glass fell more than 1%. Caustic soda, alumina, lithium carbonate, and coke fell more than 2%. Crude oil and fuel oil fell by 3%. Coking coal fell by 4%. The container shipping index plunged more than 6%. > > **10:12** The ChiNext Index turned positive, having previously fallen by over 1%. **09:47** The automotive vehicle sector strengthened, with the bus segment leading the gains. Yutong Bus and SG Automotive Group both hit the daily limit, while Zhongtong Bus Holding Co.,LTD, KLM, JMC, and Ankai saw significant increases. **09:42** Fujian local stocks were repeatedly active. Pingtan Development hit its third daily limit in five days, Mindong Electric Power hit the daily limit, Minfa Aluminum Industry rose for two consecutive days, Haixia Innovation rose more than 8%, followed by Xiamen Port, Xiamen Airport, Fujian Cement, China Minmetals Energy, and Luqiao Information. **09:37** The high-speed rail and urban rail transit concept became active again in morning trading. China Railway Signal & Communication hit its second consecutive daily limit, followed by Golden Eagle Heavy Machinery, Jiaoda Tiefa, Jinyi Industrial, TEDA Technology, Jiaoda Sino, and CRRC. According to CCTV Finance, a landmark project of the "15th Five-Year Plan" major engineering project, the high-speed railway along the Yangtze River, is under accelerated construction at the mouth of the Yangtze River. The high-speed railway will extend from Shanghai all the way to Chengdu, connecting the Yangtze River Delta, the middle reaches of the Yangtze River, and the Chengdu-Chongqing urban clusters, covering a distance of approximately 2,000 kilometers. The total investment in the high-speed railway along the Yangtze River exceeds 500 billion yuan. **09:34** The commercial aerospace concept continued its strong performance, with SHENJIAN GUFEN up for 4 consecutive trading days, followed by SHUNHO STOCK, Shaoyang Hydraulic, Zhongheng Design, Jullyar, and Chaojie Precision. **09:33** Innovative drug stocks were repeatedly active, with TJPC up for 3 consecutive trading days, followed by Asymchem, Biosan, Pharmaron, HITECK, and Novus Therapeutics. **09:26** The SSE Composite Index opened 0.02% higher, while the ChiNext Index fell by 0.8%. Technology stocks were adjusted across the board, with CPO, memory, lithium batteries, semiconductors, photovoltaics, AI computing power, and wind power concepts weakening. The consumer sector strengthened, with liquor, food, home appliances, and duty-free shop sectors seeing the largest gains. **09:21** The Hang Seng Index opened 0.27% higher, and the Hang Seng Tech Index rose by 0.08%. Midea Group rose more than 4%, while NIO and Kuaishou saw notable gains. SMIC and Hua Hong Semiconductor were among the top decliners. ### 相關股票 - [Asymchem (002821.CN)](https://longbridge.com/zh-HK/quote/002821.CN.md) - [SHENJIAN GUFEN (002361.CN)](https://longbridge.com/zh-HK/quote/002361.CN.md) - [JMC (000550.CN)](https://longbridge.com/zh-HK/quote/000550.CN.md) - [HITECK (300683.CN)](https://longbridge.com/zh-HK/quote/300683.CN.md) - [SHUNHO STOCK (002565.CN)](https://longbridge.com/zh-HK/quote/002565.CN.md) - [Ankai (000868.CN)](https://longbridge.com/zh-HK/quote/000868.CN.md) - [SG AUTOMOTIVE GROUP (600303.CN)](https://longbridge.com/zh-HK/quote/600303.CN.md) - [KLM (600686.CN)](https://longbridge.com/zh-HK/quote/600686.CN.md) - [PHARMARON (03759.HK)](https://longbridge.com/zh-HK/quote/03759.HK.md) - [TJPC (600488.CN)](https://longbridge.com/zh-HK/quote/600488.CN.md) - [Zhongtong Bus Holding Co.,LTD (000957.CN)](https://longbridge.com/zh-HK/quote/000957.CN.md) - [Pharmaron (300759.CN)](https://longbridge.com/zh-HK/quote/300759.CN.md) - [Asymchem (06821.HK)](https://longbridge.com/zh-HK/quote/06821.HK.md) - [YTCO (600066.CN)](https://longbridge.com/zh-HK/quote/600066.CN.md) - [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md) - [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-HK/quote/520690.CN.md) - [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-HK/quote/159316.CN.md) - [ChinaAMC Hang Seng Biotechnology Technology ETF(QDII) (159892.CN)](https://longbridge.com/zh-HK/quote/159892.CN.md) - [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md) - [China Universal CNI HK Connect Innovative Drugs Industry ETF (159570.CN)](https://longbridge.com/zh-HK/quote/159570.CN.md) - [Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII) (520500.CN)](https://longbridge.com/zh-HK/quote/520500.CN.md) - [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md) - [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/zh-HK/quote/513120.CN.md) - [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-HK/quote/520880.CN.md) - [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/zh-HK/quote/159992.CN.md) - [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md) - [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md) - [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md) - [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md) - [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md) ## 相關資訊與研究 - [Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase](https://longbridge.com/zh-HK/news/281231901.md) - [RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial](https://longbridge.com/zh-HK/news/281458440.md) - [Annovis Bio Director Purchased Shares Worth Over $1.4M](https://longbridge.com/zh-HK/news/281662341.md) - [SSY Group Wins China Approval for Upadacitinib Bulk Drug](https://longbridge.com/zh-HK/news/281103720.md) - [3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady](https://longbridge.com/zh-HK/news/281054154.md)